Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease.

M. G. Pittis, M. Donnarumma, A. L. Montalvo, S. Dominissini, M. Kroos, C. Rosano, M. Stroppiano, M. G. Bianco, M. A. Donati, G. Parenti, A. D'Amico, G. Ciana, M. Di Rocco, A. Reuser, B. Bembi, M. Filocamo

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We characterized 29 unrelated patients presenting with the severe form of Pompe disease (Glycogen Storage Disease Type II, acid maltase deficiency) and identified 26 pathogenic mutations divided over 28 different genotypes. Among the eight new mutations, five were exonic point mutations (c.572A>G, c.1124G>T, c.1202A>G, c.1564C>G and c.1796C>A) leading to codon changes (p.Y191C, p.R375L, p.Q401R, p.P522A and p.S599Y); two were intronic point mutations (c.-32-3C>A and c.1636+5G>C) affecting mRNA processing; one was a single base deletion (c.742delC) generating a truncated protein (p.L248PfsX20). A comprehensive evaluation, based on different methodological approaches, confirmed the detrimental effect of the eight mutations on the protein and its function. Structural alterations potentially induced by the five missense mutations were also predicted through visual inspection of the atomic model of the GAA protein, in terms of both function and spatial orientation of specific residues as well as disturbance generated by amino acid substitutions. Although the remarkable heterogeneity of the mutational spectrum in Pompe disease was already known, our data demonstrate and confirm the power of molecular and functional analysis in predicting the natural course of Pompe disease. (c) 2008 Wiley-Liss, Inc.

Original languageEnglish
JournalHuman Mutation
Volume29
Issue number6
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Glycogen Storage Disease Type II
Mutation
Point Mutation
Proteins
Missense Mutation
Amino Acid Substitution
Codon
Genotype
Messenger RNA

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease. / Pittis, M. G.; Donnarumma, M.; Montalvo, A. L.; Dominissini, S.; Kroos, M.; Rosano, C.; Stroppiano, M.; Bianco, M. G.; Donati, M. A.; Parenti, G.; D'Amico, A.; Ciana, G.; Di Rocco, M.; Reuser, A.; Bembi, B.; Filocamo, M.

In: Human Mutation, Vol. 29, No. 6, 06.2008.

Research output: Contribution to journalArticle

Pittis, MG, Donnarumma, M, Montalvo, AL, Dominissini, S, Kroos, M, Rosano, C, Stroppiano, M, Bianco, MG, Donati, MA, Parenti, G, D'Amico, A, Ciana, G, Di Rocco, M, Reuser, A, Bembi, B & Filocamo, M 2008, 'Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease.', Human Mutation, vol. 29, no. 6. https://doi.org/10.1002/humu.20753
Pittis, M. G. ; Donnarumma, M. ; Montalvo, A. L. ; Dominissini, S. ; Kroos, M. ; Rosano, C. ; Stroppiano, M. ; Bianco, M. G. ; Donati, M. A. ; Parenti, G. ; D'Amico, A. ; Ciana, G. ; Di Rocco, M. ; Reuser, A. ; Bembi, B. ; Filocamo, M. / Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease. In: Human Mutation. 2008 ; Vol. 29, No. 6.
@article{33641301d6004821b277d8c6e242e026,
title = "Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease.",
abstract = "We characterized 29 unrelated patients presenting with the severe form of Pompe disease (Glycogen Storage Disease Type II, acid maltase deficiency) and identified 26 pathogenic mutations divided over 28 different genotypes. Among the eight new mutations, five were exonic point mutations (c.572A>G, c.1124G>T, c.1202A>G, c.1564C>G and c.1796C>A) leading to codon changes (p.Y191C, p.R375L, p.Q401R, p.P522A and p.S599Y); two were intronic point mutations (c.-32-3C>A and c.1636+5G>C) affecting mRNA processing; one was a single base deletion (c.742delC) generating a truncated protein (p.L248PfsX20). A comprehensive evaluation, based on different methodological approaches, confirmed the detrimental effect of the eight mutations on the protein and its function. Structural alterations potentially induced by the five missense mutations were also predicted through visual inspection of the atomic model of the GAA protein, in terms of both function and spatial orientation of specific residues as well as disturbance generated by amino acid substitutions. Although the remarkable heterogeneity of the mutational spectrum in Pompe disease was already known, our data demonstrate and confirm the power of molecular and functional analysis in predicting the natural course of Pompe disease. (c) 2008 Wiley-Liss, Inc.",
author = "Pittis, {M. G.} and M. Donnarumma and Montalvo, {A. L.} and S. Dominissini and M. Kroos and C. Rosano and M. Stroppiano and Bianco, {M. G.} and Donati, {M. A.} and G. Parenti and A. D'Amico and G. Ciana and {Di Rocco}, M. and A. Reuser and B. Bembi and M. Filocamo",
year = "2008",
month = "6",
doi = "10.1002/humu.20753",
language = "English",
volume = "29",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease.

AU - Pittis, M. G.

AU - Donnarumma, M.

AU - Montalvo, A. L.

AU - Dominissini, S.

AU - Kroos, M.

AU - Rosano, C.

AU - Stroppiano, M.

AU - Bianco, M. G.

AU - Donati, M. A.

AU - Parenti, G.

AU - D'Amico, A.

AU - Ciana, G.

AU - Di Rocco, M.

AU - Reuser, A.

AU - Bembi, B.

AU - Filocamo, M.

PY - 2008/6

Y1 - 2008/6

N2 - We characterized 29 unrelated patients presenting with the severe form of Pompe disease (Glycogen Storage Disease Type II, acid maltase deficiency) and identified 26 pathogenic mutations divided over 28 different genotypes. Among the eight new mutations, five were exonic point mutations (c.572A>G, c.1124G>T, c.1202A>G, c.1564C>G and c.1796C>A) leading to codon changes (p.Y191C, p.R375L, p.Q401R, p.P522A and p.S599Y); two were intronic point mutations (c.-32-3C>A and c.1636+5G>C) affecting mRNA processing; one was a single base deletion (c.742delC) generating a truncated protein (p.L248PfsX20). A comprehensive evaluation, based on different methodological approaches, confirmed the detrimental effect of the eight mutations on the protein and its function. Structural alterations potentially induced by the five missense mutations were also predicted through visual inspection of the atomic model of the GAA protein, in terms of both function and spatial orientation of specific residues as well as disturbance generated by amino acid substitutions. Although the remarkable heterogeneity of the mutational spectrum in Pompe disease was already known, our data demonstrate and confirm the power of molecular and functional analysis in predicting the natural course of Pompe disease. (c) 2008 Wiley-Liss, Inc.

AB - We characterized 29 unrelated patients presenting with the severe form of Pompe disease (Glycogen Storage Disease Type II, acid maltase deficiency) and identified 26 pathogenic mutations divided over 28 different genotypes. Among the eight new mutations, five were exonic point mutations (c.572A>G, c.1124G>T, c.1202A>G, c.1564C>G and c.1796C>A) leading to codon changes (p.Y191C, p.R375L, p.Q401R, p.P522A and p.S599Y); two were intronic point mutations (c.-32-3C>A and c.1636+5G>C) affecting mRNA processing; one was a single base deletion (c.742delC) generating a truncated protein (p.L248PfsX20). A comprehensive evaluation, based on different methodological approaches, confirmed the detrimental effect of the eight mutations on the protein and its function. Structural alterations potentially induced by the five missense mutations were also predicted through visual inspection of the atomic model of the GAA protein, in terms of both function and spatial orientation of specific residues as well as disturbance generated by amino acid substitutions. Although the remarkable heterogeneity of the mutational spectrum in Pompe disease was already known, our data demonstrate and confirm the power of molecular and functional analysis in predicting the natural course of Pompe disease. (c) 2008 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=47049099971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47049099971&partnerID=8YFLogxK

U2 - 10.1002/humu.20753

DO - 10.1002/humu.20753

M3 - Article

C2 - 18429042

AN - SCOPUS:47049099971

VL - 29

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 6

ER -